Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Training the trainers: A preceptor development program targeting interprofessional collaboration competencies.

Fusco NM, Ohtake PJ.

Curr Pharm Teach Learn. 2019 Nov;11(11):1138-1143. doi: 10.1016/j.cptl.2019.07.007. Epub 2019 Aug 9.

PMID:
31783960
2.

Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers.

Pagni F, Guerini-Rocco E, Schultheis AM, Grazia G, Rijavec E, Ghidini M, Lopez G, Venetis K, Croci GA, Malapelle U, Fusco N.

Int J Mol Sci. 2019 Nov 1;20(21). pii: E5452. doi: 10.3390/ijms20215452. Review.

3.

Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.

Fusco NM, Meaney CJ, Frederick CA, Prescott WA Jr.

Ann Pharmacother. 2019 Oct 29:1060028019885651. doi: 10.1177/1060028019885651. [Epub ahead of print]

PMID:
31658825
4.

Common bacterial infections and their treatment in hospitalized pediatric patients.

Fusco NM, Nichols K.

Am J Health Syst Pharm. 2019 Sep 16;76(19):1521-1531. doi: 10.1093/ajhp/zxz164.

PMID:
31532502
5.

Improving Pharmacy Students' Attitudes Toward Collaborative Practice Through a Large-scale Interprofessional Forum Targeting Opioid Dependence.

Fusco NM, Maerten-Rivera J, Doloresco F, Ohtake PJ.

Am J Pharm Educ. 2019 Aug;83(6):7034. doi: 10.5688/ajpe7034.

6.

Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events.

Mayo-Wilson E, Fusco N, Hong H, Li T, Canner JK, Dickersin K.

Trials. 2019 Sep 5;20(1):553. doi: 10.1186/s13063-019-3581-3.

7.

Systemic and oral conditions of pregnant women with excessive weight assisted in a private health system.

Fusco NDS, Foratori-Junior GA, Missio ALT, Jesuino BG, Sales-Peres SHC.

Int Dent J. 2019 Dec;69(6):472-479. doi: 10.1111/idj.12507. Epub 2019 Jul 31.

PMID:
31368161
8.

Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability.

Fusco N, Lopez G, Corti C, Pesenti C, Colapietro P, Ercoli G, Gaudioso G, Faversani A, Gambini D, Michelotti A, Despini L, Blundo C, Vaira V, Miozzo M, Ferrero S, Bosari S.

JNCI Cancer Spectr. 2018 Dec 13;2(4):pky056. doi: 10.1093/jncics/pky056. eCollection 2018 Oct.

9.

Traumatic Corneal Abrasion.

Fusco N, Stead TG, Lebowitz D, Ganti L.

Cureus. 2019 Apr 5;11(4):e4396. doi: 10.7759/cureus.4396.

10.

The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience.

Vigliar E, Malapelle U, Bono F, Fusco N, Cortinovis D, Valtorta E, Spyridon A, Bimbatti M, Zocchi M, Piva C, Gaudioso G, Iaccarino A, Morbini P, Pagni F.

Biomed Res Int. 2019 Apr 14;2019:6832909. doi: 10.1155/2019/6832909. eCollection 2019.

11.

A novel integrated platform for the identification of surgical margins in oral squamous cell carcinoma: results from a prospective single-institution series.

Baj A, Fusco N, Bolzoni A, Carioli D, Mazzucato C, Faversani A, Bresciani L, Maggioni M, Capaccio P.

BMC Cancer. 2019 May 17;19(1):467. doi: 10.1186/s12885-019-5634-0.

12.

The conundrum of breast chondrolipoma: Heterotopic, metaplastic, or neoplastic lesion?

Sabella G, Lopez G, Runza L, Rognoni E, Sfondrini MS, Fusco N.

Breast J. 2019 Jul;25(4):733-734. doi: 10.1111/tbj.13316. Epub 2019 May 14. No abstract available.

PMID:
31090158
13.

TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall.

Jaconi M, Magni F, Raimondo F, Ponzoni M, Chinello C, Smith A, Piga I, Fusco N, Di Bella C, Pagni F.

J Clin Pathol. 2019 Aug;72(8):536-541. doi: 10.1136/jclinpath-2019-205713. Epub 2019 May 4.

PMID:
31055472
14.

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events.

Mayo-Wilson E, Fusco N, Li T, Hong H, Canner JK, Dickersin K; MUDS investigators.

J Clin Epidemiol. 2019 Sep;113:11-19. doi: 10.1016/j.jclinepi.2019.04.020. Epub 2019 May 2. Review.

15.

Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events.

Mayo-Wilson E, Fusco N, Li T, Hong H, Canner JK, Dickersin K; MUDS investigators.

J Clin Epidemiol. 2019 Sep;113:20-27. doi: 10.1016/j.jclinepi.2019.04.022. Epub 2019 May 2. Review.

16.

The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity.

Pesenti C, Navone SE, Guarnaccia L, Terrasi A, Costanza J, Silipigni R, Guarneri S, Fusco N, Fontana L, Locatelli M, Rampini P, Campanella R, Tabano S, Miozzo M, Marfia G.

Stem Cells Int. 2019 Mar 7;2019:2617030. doi: 10.1155/2019/2617030. eCollection 2019.

17.

Diagnostic challenge of intrathoracic tissue misplacements: a thymic choristoma in a fetal lung.

Lopez G, Croci R, Rizzuti T, Ferrero S, Fusco N.

Thorax. 2019 Jun;74(6):624. doi: 10.1136/thoraxjnl-2019-213242. Epub 2019 Apr 2. No abstract available.

PMID:
30940769
18.

Determination of Mismatch Repair Status in Human Cancer and Its Clinical Significance: Does One Size Fit All?

Corti C, Sajjadi E, Fusco N.

Adv Anat Pathol. 2019 Jul;26(4):270-279. doi: 10.1097/PAP.0000000000000234.

19.

NF1 Alterations are Linked to Increased HER2 Expression in Breast Cancer-Letter.

Gambini D, Natacci F, Cesaretti C, Fusco N.

Cancer Prev Res (Phila). 2019 Mar;12(3):195-196. doi: 10.1158/1940-6207.CAPR-18-0392. Epub 2019 Feb 21. No abstract available.

PMID:
30792346
20.

Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors.

Lopez G, Costanza J, Colleoni M, Fontana L, Ferrero S, Miozzo M, Fusco N.

Int J Mol Sci. 2019 Jan 25;20(3). pii: E510. doi: 10.3390/ijms20030510.

21.

Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab.

Invernizzi M, Michelotti A, Noale M, Lopez G, Runza L, Giroda M, Despini L, Blundo C, Maggi S, Gambini D, Fusco N.

J Clin Med. 2019 Jan 24;8(2). pii: E138. doi: 10.3390/jcm8020138.

22.

Tackling the diversity of breast cancer related lymphedema: Perspectives on diagnosis, risk assessment, and clinical management.

Michelotti A, Invernizzi M, Lopez G, Lorenzini D, Nesa F, De Sire A, Fusco N.

Breast. 2019 Apr;44:15-23. doi: 10.1016/j.breast.2018.12.009. Epub 2018 Dec 17. Review.

PMID:
30580170
23.

Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability.

Colombo C, Muzza M, Proverbio MC, Tosi D, Soranna D, Pesenti C, Rossi S, Cirello V, De Leo S, Fusco N, Miozzo M, Bulfamante G, Vicentini L, Ferrero S, Zambon A, Tabano S, Fugazzola L.

Thyroid. 2019 Feb;29(2):237-251. doi: 10.1089/thy.2018.0339. Epub 2019 Jan 16.

PMID:
30501571
24.

Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma.

Lopez G, Boggio F, Ferrero S, Fusco N, Del Gobbo A.

Int J Mol Sci. 2018 Oct 3;19(10). pii: E3014. doi: 10.3390/ijms19103014. Review.

25.

Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up.

Invernizzi M, Corti C, Lopez G, Michelotti A, Despini L, Gambini D, Lorenzini D, Guerini-Rocco E, Maggi S, Noale M, Fusco N.

BMC Cancer. 2018 Sep 29;18(1):935. doi: 10.1186/s12885-018-4851-2.

26.

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal.

Pelosi G, Papotti M, Righi L, Rossi G, Ferrero S, Bosari S, Calabrese F, Kern I, Maisonneuve P, Sonzogni A, Albini A, Harari S, Barbieri F, Capelletto E, Catino AM, Cavone D, De Palma A, Fusco N, Lunardi F, Maiorano E, Marzullo A, Novello S, Papanikolaou N, Pasello G, Pennella A, Pezzuto F, Punzi A, Prisciandaro E, Rea F, Rosso L, Scattone A, Serio G.

J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.

27.

Caveat emptor: the combined effects of multiplicity and selective reporting.

Li T, Mayo-Wilson E, Fusco N, Hong H, Dickersin K.

Trials. 2018 Sep 17;19(1):497. doi: 10.1186/s13063-018-2888-9.

28.

CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report.

Del Gobbo A, Fusco N, Barella M, Ercoli G, Sciarra A, Palleschi A, Pagni F, Marchiò C, Papotti M, Ferrero S.

Cell Oncol (Dordr). 2018 Dec;41(6):687-691. doi: 10.1007/s13402-018-0401-9. Epub 2018 Sep 4.

PMID:
30182340
29.

Methods to identify and prioritize patient-centered outcomes for use in comparative effectiveness research.

Mayo-Wilson E, Golozar A, Cowley T, Fusco N, Gresham G, Haythornthwaite J, Tolbert E, Payne JL, Rosman L, Hutfless S, Canner JK, Dickersin K.

Pilot Feasibility Stud. 2018 Jun 12;4:95. doi: 10.1186/s40814-018-0284-6. eCollection 2018.

30.

Molecular Determinants of Substrate Specificity in Human Insulin-Degrading Enzyme.

Stefanidis L, Fusco ND, Cooper SE, Smith-Carpenter JE, Alper BJ.

Biochemistry. 2018 Aug 14;57(32):4903-4914. doi: 10.1021/acs.biochem.8b00474. Epub 2018 Jul 25.

PMID:
30004674
31.

Measuring changes in pharmacy and nursing students' perceptions following an interprofessional high-fidelity simulation experience.

Fusco NM, Foltz-Ramos K.

J Interprof Care. 2018 Sep;32(5):648-652. doi: 10.1080/13561820.2018.1496073. Epub 2018 Jul 6.

PMID:
29979905
32.

Chondroid Differentiation in Thyroid Nodular Hyperplasia: An Innocent Bystander?

Pittaro A, Del Gobbo A, Iofrida E, Fusco N.

Int J Surg Pathol. 2019 May;27(3):274. doi: 10.1177/1066896918781741. Epub 2018 Jul 2. No abstract available.

PMID:
29961394
33.

Diagnostic imaging of hepatic tuberculosis: case series.

Schininà V, Albarello F, Cristofaro M, Di Stefano F, Fusco N, Cuzzi G, Arend SM, Goletti D, Busi Rizzi E.

Int J Tuberc Lung Dis. 2018 Jul 1;22(7):779-787. doi: 10.5588/ijtld.17.0710.

PMID:
29914604
34.

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.

De Mattos-Arruda L, Ng CKY, Piscuoglio S, Gonzalez-Cao M, Lim RS, De Filippo MR, Fusco N, Schultheis AM, Ortiz C, Viteri S, Arias A, Macedo GS, Oliveira M, Gomez P, Teixidó C, Nuciforo P, Peg V, Saura C, Ramon Y Cajal S, Casas FT, Weigelt B, Cortes J, Seoane J, Reis-Filho JS.

Oncotarget. 2018 Apr 17;9(29):20617-20630. doi: 10.18632/oncotarget.25041. eCollection 2018 Apr 17.

35.

Pharmacokinetic Monitoring of Vancomycin in Cystic Fibrosis: Is It Time to Move Past Trough Concentrations?

Fusco NM, Prescott WA Jr, Meaney CJ.

Pediatr Infect Dis J. 2019 Mar;38(3):258-262. doi: 10.1097/INF.0000000000002088.

PMID:
29742643
36.

Vancomycin Versus Vancomycin Plus Rifampin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.

Fusco NM, Meaney CJ, Wells C, Frederick CA, Prescott WA Jr.

J Pediatr Pharmacol Ther. 2018 Mar-Apr;23(2):125-131. doi: 10.5863/1551-6776-23.2.125.

37.

Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.

Smith A, Galli M, Piga I, Denti V, Stella M, Chinello C, Fusco N, Leni D, Manzoni M, Roversi G, Garancini M, Pincelli AI, Cimino V, Capitoli G, Magni F, Pagni F.

J Proteomics. 2019 Jan 16;191:114-123. doi: 10.1016/j.jprot.2018.03.021. Epub 2018 Mar 24.

PMID:
29581064
38.

Correction to: Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol.

Mayo-Wilson E, Hutfless S, Li T, Gresham G, Fusco N, Ehmsen J, Heyward J, Vedula S, Lock D, Haythornthwaite J, Payne JL, Cowley T, Tolbert E, Rosman L, Twose C, Stuart EA, Hong H, Doshi P, Suarez-Cuervo C, Singh S, Dickersin K.

Syst Rev. 2018 Mar 19;7(1):48. doi: 10.1186/s13643-018-0711-z.

39.

Rathke's cleft cyst associated with pituitary granulomatosis with polyangiitis: An unusual combination of hypothalamus-pituitary region pathologies.

Draghi R, Mantovani G, Runza L, Carrabba G, Fusco N, Rampini P, Costa A, Locatelli M.

Radiol Case Rep. 2017 Oct 31;13(1):233-236. doi: 10.1016/j.radcr.2017.09.018. eCollection 2018 Feb.

40.

Correction to: Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review.

Mayo-Wilson E, Hutfless S, Li T, Gresham G, Fusco N, Ehmsen J, Heyward J, Vedula S, Lock D, Haythornthwaite J, Payne JL, Cowley T, Tolbert E, Rosman L, Twose C, Stuart EA, Hong H, Doshi P, Suarez-Cuervo C, Singh S, Dickersin K.

Alzheimers Res Ther. 2018 Feb 16;10(1):20. doi: 10.1186/s13195-018-0351-5.

41.

Characterization of Vaccination Policies for Attendance and Employment at Day/Summer Camps in New York State.

Prescott WA Jr, Violanti KC, Fusco NM.

J Pharm Pract. 2019 Aug;32(4):382-387. doi: 10.1177/0897190017751947. Epub 2018 Jan 11.

PMID:
29325483
42.

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers.

Ercoli G, Lopez G, Ciapponi C, Corti C, Despini L, Gambini D, Runza L, Blundo C, Sciarra A, Fusco N.

J Vis Exp. 2017 Dec 5;(130). doi: 10.3791/56686.

43.

Looking for sputum biomarkers in lung cancer secondary prevention: where are we now?

Fusco N, Fumagalli C, Guerini-Rocco E.

J Thorac Dis. 2017 Nov;9(11):4277-4279. doi: 10.21037/jtd.2017.10.22. No abstract available.

44.

MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.

Kim J, Geyer FC, Martelotto LG, Ng CK, Lim RS, Selenica P, Li A, Pareja F, Fusco N, Edelweiss M, Kumar R, Gularte-Merida R, Forbes AN, Khurana E, Mariani O, Badve S, Vincent-Salomon A, Norton L, Reis-Filho JS, Weigelt B.

J Pathol. 2018 Feb;244(2):143-150. doi: 10.1002/path.5006. Epub 2017 Dec 28.

45.

Columnar Cell Lesion and Apocrine Hyperplasia of the Breast: Is There a Common Origin? The Role of Prolactin-induced Protein.

Sciarra A, Lopez G, Corti C, Runza L, Ercoli G, Bonometti A, Despini L, Blundo C, Gambini D, Fusco N.

Appl Immunohistochem Mol Morphol. 2019 Aug;27(7):508-514. doi: 10.1097/PAI.0000000000000604.

PMID:
29084054
46.

Practical guidance for using multiple data sources in systematic reviews and meta-analyses (with examples from the MUDS study).

Mayo-Wilson E, Li T, Fusco N, Dickersin K; MUDS investigators.

Res Synth Methods. 2018 Mar;9(1):2-12. doi: 10.1002/jrsm.1277. Epub 2017 Dec 15.

47.

Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.

Holsen MR, Meaney CJ, Hassinger AB, Fusco NM.

Pediatr Crit Care Med. 2017 Dec;18(12):e585-e591. doi: 10.1097/PCC.0000000000001335.

PMID:
28906422
48.

Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.

Fusco NM, Francisconi R, Meaney CJ, Duman D, Frederick CA, Prescott WA.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e103-e108. doi: 10.1093/jpids/pix043.

PMID:
28903517
49.

Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy.

Mayo-Wilson E, Li T, Fusco N, Bertizzolo L, Canner JK, Cowley T, Doshi P, Ehmsen J, Gresham G, Guo N, Haythornthwaite JA, Heyward J, Hong H, Pham D, Payne JL, Rosman L, Stuart EA, Suarez-Cuervo C, Tolbert E, Twose C, Vedula S, Dickersin K.

J Clin Epidemiol. 2017 Nov;91:95-110. doi: 10.1016/j.jclinepi.2017.07.014. Epub 2017 Aug 24. Review.

50.

Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells.

Peverelli E, Catalano R, Giardino E, Treppiedi D, Morelli V, Ronchi CL, Vaczlavik A, Fusco N, Ferrero S, Bertherat J, Beuschlein F, Chiodini I, Arosio M, Spada A, Mantovani G.

Cancer Lett. 2017 Oct 10;406:54-63. doi: 10.1016/j.canlet.2017.07.025. Epub 2017 Aug 5.

Supplemental Content

Support Center